In this study, we identified CEACAM1 as a key factor that supports BCR signaling in MCL through a comprehensive approach combining genome-wide CRISPR screens, gene expression profiling, and BCR signal transduction studies. This evidence concerns the gene BCR and mantle cell lymphoma.